Oxidative stress and mitochondrial dysfunction in sepsis

British Journal of Anaesthesia

Volumn 107, Issue 1, 2011, Pages 57-64

  Galley, H F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

antioxidants; mitochondria; oxidative stress; sepsis

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; MELATONIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; INFLAMMATION; INTENSIVE CARE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEPSIS;

EID: 79959412738     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer093     Document Type: Review

References (76)

1. Marshall JC, Vincent JL, Guyatt G, et al. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med 2005; 33: 1708-16
2. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13
3. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552: 335-44 (Pubitemid 37321833)
4. Kaakar P, Singh BK. Mitochondria: a hub of redox activities and cellular distress control. Mol Cell Biochem 2007; 305: 235-53 (Pubitemid 47517185)
5. Brown GC, Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta 2004; 1658: 44-9 (Pubitemid 39013232)
6. Ghafourifar P, Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 2005; 26: 190-5 (Pubitemid 40432654)
7. Lacza Z, Pankotai E, Csordás A, et al. Mitochondrial NO and reactive nitrogen species production: does mtNOS exist? Nitric Oxide 2006; 14: 162-8 (Pubitemid 43165882)
8. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95 (Pubitemid 34654215)
9. James AM, Murphy MP. How mitochondrial damage affects cell function. J Biomed Sci 2002; 9: 475-87 (Pubitemid 35316860)
10. Ozawa T. Mitochondrial genome mutation in cell death and ageing. J Bioenerg Biomembr 1999; 31: 377-90 (Pubitemid 30058572)
11. Van-Remmen H, Richardson A. Oxidative damage to mitochondria and ageing. Exp Gerontol 2001; 36: 957-68
12. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. Role of mitochondria in toxic oxidative stress. Mol Interv 2005; 5: 94-111 (Pubitemid 40590509)
13. Zhang H, Go YM, Jones DP. Mitochondrial thioredoxin-2/ peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys 2007; 465: 119-26 (Pubitemid 47283985)
14. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008; 295: C849-68
15. Watabe S, Hiroi T, Yamamoto Y, et al. SP-22 is a thioredox-independent peroxide reductase in mitochondria. Eur J Biochem 1997; 249: 52-60 (Pubitemid 27432595)
16. PatenaudeA,Ven Murthy MR, Mirault ME. Mitochondrial thioredoxin system\-effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis. J Biol Chem 2004; 279: 27302-14
17. Lowes DA, Galley HF. Mitochondrial protection by the thioredoxin-2 and glutathione systems in an in vitro endothelial model of sepsis. Biochem J 2011 Feb 28 [Epub ahead of print]
18. Goode HF, Cowley HC, Walker BE, Webster NR. Decreased antiox-idant status and increased lipid peroxidation in patients with sepsis and secondary organ dysfunction. Crit Care Med 1995; 23: 646-51
19. Galley HF, Davies MJ, Webster NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24: 1649-53 (Pubitemid 26347376)
20. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in sepsis: a comparison of survivors and non-survivors. Crit Care Med 1996; 24: 1179-83 (Pubitemid 26249370)
21. Chuang CC, Shiesh SC, Chi CH, et al. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 2006; 10: R36
22. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24: 392-97 (Pubitemid 26097830)
23. Cross CE, Forte T, Stocker R, et al. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 1990; 115: 396-404 (Pubitemid 20143386)
24. Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 1995; 20: 139-143 (Pubitemid 26014329)
25. Arnalich F, Garcia-Palomero E, Lopez J. Predictive value of NFkB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000; 68: 1942-5 (Pubitemid 30164821)
26. Paterson RL, Galley HF, Dhillon JK, Webster NR. Increased NFkB activation in critically ill patients who die. Crit Care Med 2000; 28: 1047-51 (Pubitemid 30262076)
27. Hill AL, Lowes DA, Webster NR, Sheth CC, Gow NA, Galley HF. Regulation of pentraxin-3 by antioxidants. Br J Anaesth 2009; 103: 833-39
28. Crouser ED. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 2004; 4: 729-41 (Pubitemid 39646818)
29. Brealey D, Singer M. Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep 2003; 5: 365-71 (Pubitemid 38914985)
30. Brealey DA, Hargreaves I, Heales S, Land J, Smolenski R, Singer M. Recovery from organ failure is associated with improved mito-chondrial function in septic patients (abstract). Intensive Care Med 2003; 29: S134
31. Brealey D, Karyampudi S, Jacques TS, et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286: R491-7 (Pubitemid 38252613)
32. Gellerich FN, Trumbeckaite S, Hertel K, et al. Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. Shock 1999; 11: 336-41
33. Crouser ED, Julian MW, Blaho DV, Pfeiffer DR. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002; 30: 276-84 (Pubitemid 34158107)
34. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mito-chondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365: 53-9 (Pubitemid 40082146)
35. Yassen K, Galley HF, Lee A, Webster NR. Mitochondrial redox state in the critically ill. Br J Anaesth 1999; 83: 325-7 (Pubitemid 29361147)
36. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360: 219-23 (Pubitemid 34804650)
37. Azevedo LC. Mitochondrial dysfunction during sepsis. Endocr Metab Immune Disord Drug Targets 2010; 10: 214-23
38. Dare AJ, Phillips AR, Hickey AJ, et al. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 2009; 47: 1517-25
39. Mishra V. Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab 2007; 53: 199-209 (Pubitemid 46656577)
40. Rinaldi S, Landucci F, De Gaudio AR. Antioxidant therapy in critically ill septic patients. Curr Drug Targets 2009; 10: 872-80
41. Víctor VM, Espulgues JV, Hernández-Mijares A, Rocha M. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets 2009; 9: 376-89
42. Galley HF. Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis. Crit Care 2010; 14: 230
43. Subramanian S, Kalyanaraman B, Migrino RQ. Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2010; 5: 54-65
44. Smith RAJ, Porteous AM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999; 263: 709-16 (Pubitemid 29361943)
45. Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010; 1201: 96-103
46. Kelso GF, Porteous CM, Coulter CV, et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 2001; 276: 4588-96
47. Dhanasekaran A, Kotamraju S, Kalivendi SV,et al. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem 2004; 279: 37575-87 (Pubitemid 39195471)
48. Bedogni B, Pani G, Colavitti R, Riccio A, et al. Redox regulation of cAMP-responsive element-binding protein and induction of man-ganous superoxide dismutase in nerve growth factor-dependent cell survival. J Biol Chem 2003; 278: 16510-9 (Pubitemid 36799511)
49. Smith RAJ, Porteous C, Gane AM, Murphy MP. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA 2003; 100: 5407-12 (Pubitemid 36542718)
50. Adlam VJ, Harrison JC, Porteous CM, et al. Targeting an antioxi-dant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005; 19: 1088-95 (Pubitemid 40946434)
51. Graham D, Huynh NN, Hamilton CA, et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009; 54: 322-8
52. Esplugues JV, Rocha M, Nuñez C, et al. Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 2006; 99: 1067-75 (Pubitemid 44729930)
53. Filipovska A, Kelso GF, Brown SE, Beer SM, Smith RAJ, Murphy MP. Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. J Biol Chem 2005; 280: 24113-26
54. Skulachev VP, Anisimov VN, Antonenko YN, et al. An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta 2009; 1787: 437-61
55. Wipf P, Xiao J, Jiang J, et al. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPOL conjugates. J Am Chem Soc 2005; 127: 12460-1 (Pubitemid 41292143)
56. Fink MP, Macias CA, Xiao J, et al. Hemigramicidin-TEMPOL conjugates: novel mitochondria-targeted antioxidants. Crit Care Med 2007; 35: S461-7 (Pubitemid 47312180)
57. Macias CA, Chiao JW, Xiao J, et al. Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg 2007; 245: 305-14 (Pubitemid 46148491)
58. Zhao K, Zhao GM, Wu D, et al. Cell-permeable peptide antioxi-dants targeted to inner mitochondrial membrane inhibit mito-chondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004; 279: 34682-90 (Pubitemid 39318098)
59. Szeto HH. Mitochondria-targeted cytoprotective peptides for ische-mia-reperfusion injury. Antioxid Redox Signal 2008; 10: 601-19
60. Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 2006; 1762: 256-65 (Pubitemid 43006031)
61. Wheeler MD, Nakagami M, Bradford BU, et al. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J Biol Chem 2001; 276: 36664-72
62. Wheeler MD, Katuna M, Smutney OM, et al. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum Gene Ther 2001; 12: 2167-77 (Pubitemid 34081176)
63. Spasojević I, Chen Y, Noel TJ, et al. Mn porphyrin-based superox-ide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria. Free Radic Biol Med 2007; 42: 1193-200 (Pubitemid 46437360)
64. Lowes DA, Almawash AM, Webster NR, Galley HF. Role of melato-nin and indole-derivatives on endothelial cells in an in vitro model of sepsis (abstract). Br J Anaesth 2010; 104: 525P
65. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-50
66. Roser KS, Brookes PS, Wojtovich AP, et al. Mitochondrial biotrans-formation of omega-(phenoxy)alkanoic acids, 3-(phenoxy)acrylic acids, and omega-(1-methyl-1H-imidazol-2-ylthio)alkanoic acids: a prodrug strategy for targeting cytoprotective antioxidants to mitochondria. Bioorg Med Chem 2010; 18: 1441-8
67. Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 2008; 45: 1559-65
68. Minter BE, Lowes DA, Webster NR, Galley HF. Mitochondrial targeted vitamin E in an endothelial model of sepsis (abstract). Br J Anaesth 2010; 104: 525-6P
69. Lowes DA, Webster NR, Murphy MP, Galley HF. Effects of mitochondria targeted antioxidants on biochemical markers of organ function and interleukin-6 in an in vivo model of sepsis (abstract). Br J Anaesth 2010; 105: 719-20P
70. Supinski GS, Murphy MP, Callahan LA. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1095-102
71. Escames G, López LC, Ortiz F, et al. Attenuation of cardiac mito-chondrial dysfunction by melatonin in septic mice. FEBS Lett 2007; 274: 2135-47 (Pubitemid 46588010)
72. Sener G, Toklu H, Kapucu C, et al. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today 2005; 35: 52-9 (Pubitemid 40941131)
73. Vanasco V, Cimolai MC, Pablo Evelson P, Silvia Alvarez S. The oxidative stress and the mitochondrial dysfunction caused by endotoxemia are prevented by a-lipoic acid. Free Radic Res 2008; 42: 815-23
74. Pandit JJ, Handy JM. Science, anaesthesia and animal studies. What is 'evidence'? Anaesthesia 2010; 65: 223-6
75. Fink MP. Animal models of sepsis and its complications. Kidney Int 2008; 74: 991-3
76. Dyson A, Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 2009; 37: S30-7